124 related articles for article (PubMed ID: 10149510)
1. Clinical experience with heparin-coated cardiopulmonary bypass circuits.
Pradhan MJ; Fleming JS; Nkere UU; Arnold J; Wildlevuur CR; Taylor KM
Perfusion; 1991; 6(3):235-42. PubMed ID: 10149510
[TBL] [Abstract][Full Text] [Related]
2. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
3. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
5. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
[TBL] [Abstract][Full Text] [Related]
7. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass.
Moen O; Høgåsen K; Fosse E; Dregelid E; Brockmeier V; Venge P; Harboe M; Mollnes TE
Ann Thorac Surg; 1997 Jan; 63(1):105-11. PubMed ID: 8993250
[TBL] [Abstract][Full Text] [Related]
9. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
[TBL] [Abstract][Full Text] [Related]
10. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P
Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
[TBL] [Abstract][Full Text] [Related]
11. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
[TBL] [Abstract][Full Text] [Related]
12. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.
Gu YJ; van Oeveren W; Akkerman C; Boonstra PW; Huyzen RJ; Wildevuur CR
Ann Thorac Surg; 1993 Apr; 55(4):917-22. PubMed ID: 8466349
[TBL] [Abstract][Full Text] [Related]
13. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits.
Jansen PG; te Velthuis H; Huybregts RA; Paulus R; Bulder ER; van der Spoel HI; Bezemer PD; Slaats EH; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):829-34. PubMed ID: 7564452
[TBL] [Abstract][Full Text] [Related]
14. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
Kuitunen AH; Heikkilä LJ; Salmenperä MT
Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
[TBL] [Abstract][Full Text] [Related]
17. The effects of methylprednisolone on complement, immunoglobulins and pulmonary neutrophil sequestration during cardiopulmonary bypass.
Dernek S; Tünerir B; Sevin B; Aslan R; Uyguç O; Kural T
Cardiovasc Surg; 1999 Jun; 7(4):414-8. PubMed ID: 10430523
[TBL] [Abstract][Full Text] [Related]
18. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
[TBL] [Abstract][Full Text] [Related]
19. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population.
Videm V; Mollnes TE; Fosse E; Mohr B; Bergh K; Hagve TA; Aasen AO; Svennevig JL
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):794-802. PubMed ID: 10096976
[TBL] [Abstract][Full Text] [Related]
20. Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial.
Belboul A; Löfgren C; Storm C; Jungbeck M
Eur J Cardiothorac Surg; 2000 May; 17(5):580-6. PubMed ID: 10814923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]